Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile.
about
Role of Akt signaling in resistance to DNA-targeted therapyPhase I trial of weekly topotecan and gemcitabine in patients with solid tumors.A phase I study of topotecan and gemcitabine in advanced solid tumors.Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer.Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells.Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatin.Pharmacogenetic screening of the gene deletion and duplications of CYP2D6.The promise of PET in clinical management and as a sensitive test for drug cytotoxicity in sarcomas.Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development.Inhalable, large porous PLGA microparticles loaded with paclitaxel: preparation, in vitro and in vivo characterization.Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxiaEffect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.Andrographolide potentiates the antitumor effect of topotecan in acute myeloid leukemia cells through an intrinsic apoptotic pathway.Pharmacokinetic/pharmacodynamic modeling of combination-chemotherapy for lung cancer
P2860
Q28066950-DD53105E-10EF-450F-8BF1-038A8F0240F6Q33383131-B65C1E8A-3D59-4B7B-B686-429A15D3C393Q33390366-13308376-54C8-4234-BA6D-9F561A3D01F6Q34079286-F9A0678C-B3E9-4B46-9499-E80D46E79724Q36157197-C33DC4FE-5908-4840-8189-DE04AB4CE5ABQ36616830-965F13B5-A287-4170-8307-356B3174B5C4Q36761673-F4F02F43-48AD-44FC-9A14-D2525CC28531Q37035291-088B2C58-E395-417A-B1F8-A7EF606D3288Q38088759-927AF7D2-5839-42A0-903E-415806F1A7CEQ38831758-46A7E5C9-91CC-4196-98AA-C0BD98E9D11BQ39068039-02C974E1-486E-483D-B85F-C5A5498C9ABEQ51806224-A4A998FC-BD87-4794-9CF9-8D68244EA474Q54969600-D1359124-525E-4608-956A-1550F7B06F70Q57176872-6AACC2D4-F312-418A-9B14-EF89327C92CE
P2860
Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Interaction between gemcitabin ...... e and pharmacogenetic profile.
@en
type
label
Interaction between gemcitabin ...... e and pharmacogenetic profile.
@en
prefLabel
Interaction between gemcitabin ...... e and pharmacogenetic profile.
@en
P2093
P2860
P50
P356
P1476
Interaction between gemcitabin ...... le and pharmacogenetic profile
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602382
P407
P577
2005-02-01T00:00:00Z